PO Box 12878
6 Davis Drive, Suite 827
Boragen, established in 2017 in Research Triangle Park, is focused on leveraging the unique chemical properties of boron to develop novel synthetic chemistry platforms to produce next-generation fungicides that support more sustainable farming methods. The company’s lead compound decreases the probability of fungicide resistance and reduces the amount of chemical applied while maintaining performance and efficacy.
Founders: Stephen Benkovic, Gerald Fink, Paul Schimmel, Tony Liu and Lucy Shapiro
CEO: John W. Dombrosky
Founder and CSO: Tony Liu
11 articles with Boragen
Dr. Brian Metcalf Joins Distinguished Scientists on Boragen’s Scientific Advisory Board
Boragen Inc., a world-leading boron-based discovery platform, today announced that it has added Dr. Brian Metcalf to its Scientific Advisory Board.
National Institutes of Health Awards Boragen $300,500 Grant for Antimalarial Drug Discovery
Boragen, Inc. has been awarded a $300,500 Phase I Small Business Innovation Research grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
Boragen Collaborates with Dole to Develop Boron-based Treatment for Major Banana Disease
Boragen Inc., a world-leading boron-based discovery platform, is proud to announce a collaboration with Dole Fresh Fruit Company, a subsidiary of Dole Food Company, Inc. Dole is focused on finding innovative and more sustainable solutions to protect against Black Sigatoka, one of the most prevalent and damaging diseases affecting the banana. “As pressure to reduce chemical load increases, and the number
Boragen Collaborates With Leading Universities to Extend the Benefits of Its Boron-based Platform Across Agriculture, Animal Health and Human Health
Feb. 11, 2020 14:00 UTC RESEARCH TRIANGLE PARK, N.C.--( BUSINESS WIRE )-- Boragen, Inc. , a world-leading boron-based discovery platform, today announced that the company has partnered with the University of Toronto, University of Vermont and University of California, San Francisco to further its mission of creating innovative solutions based on the unique properties of boron-based chemistry. “Boron continues to surprise us on a regular basis, and integration of boron into a
Boragen Signs Deal with a Leading Animal Health Company for Discovery and Development of Canine Atopic Dermatitis Treatment
As part of this R&D agreement, the company will have an exclusive option to a license to develop and commercialize lead compounds in the Animal Health Field.
Boragen Adds Dr. Mark Zettler to Growing Scientific Advisory Board
Dr. Zettler brings over 30 years of leadership experience across the global pre- and post-harvest food and agriculture industries.
It’s hard to believe 2018 is half over. There have been plenty of interesting and important stories in the biopharma space this year. Here’s a look at our top 10 stories so far, counting down from 10 to the number one story.
Think biotechnology, you probably think cutting-edge development of drugs to treat diseases. Yet in 2007, a U.S. EPA report noted that industrial biotechnology and biobased manufacturing are more efficient, cleaner and make better use of sustainable renewable resources.
What You Need to Know About Boragen
1/10/2018Boragen is located in Research Triangle Park in Durham, N.C., and focuses on boron-based development of anti-bacterials and anti-fungicides for the agricultural industry.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
AgTech Accelerator Launches First Investment In Novel Fungicide Company, Boragen, With $10 Million Series A Financing